Enteric fever, commonly known as typhoid fever, is a systemic infection caused by Salmonella Typhi or Paratyphi. Despite advancements in diagnostic methods and treatment, it remains a significant global health issue, particularly in low-resource settings. This article aims to provide a comprehensive guide for healthcare professionals to optimize diagnosis and treatment strategies for enteric fever.
Diagnosing enteric fever can be challenging due to its nonspecific symptoms and the limitations of current diagnostic tests. Blood culture, the gold standard for diagnosis, has a sensitivity of only 40-60%. There is a pressing need for improved diagnostic tools that are both accurate and practical for use in resource-limited settings.
Recent advancements have led to the development of rapid diagnostic tests (RDTs), which offer promising results. These tests, based on the detection of specific antigens or antibodies, provide results within hours. However, more research is needed to establish their reliability and cost-effectiveness.
The mainstay of treatment for enteric fever is antibiotic therapy. However, the emergence of multi-drug resistant (MDR) strains has complicated treatment strategies. Fluoroquinolones have been the drugs of choice, but resistance to these is increasing, necessitating the use of third-generation cephalosporins or azithromycin.
With the rising trend of antibiotic resistance, the future lies in vaccine development. Current vaccines have limitations, but new-generation vaccines are under development. In addition, novel therapeutic strategies, such as the use of bacteriophages, are being explored.
Optimizing the diagnosis and treatment of enteric fever requires a multifaceted approach, encompassing the development of improved diagnostic tools, effective treatment regimens, and preventive measures. By staying abreast of emerging strategies, healthcare professionals can play a crucial role in managing this global health issue.
1.
More evidence links physical activity with improved cancer survival
2.
Base-edited T-cell therapy offers additional hope for treating resistant leukemia.
3.
Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.
4.
In schizophrenia, sexual dysfunction is frequent.
5.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
1.
The Role of Calcium Corrections in Accurate Blood Test Results
2.
Clonal Hematopoiesis and Healthy Aging: Insights, Mechanisms, and Clinical Relevance
3.
Hematopoietic Stem Cell Fitness Biomarkers: Clinical Relevance and Emerging Paradigms
4.
Cemiplimab: A Revolutionary Drug For Treating Cancer
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Blood Clotting Disorders Explained
4.
Efficient Management of First line ALK-rearranged NSCLC - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation